Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
Vora, Ajay, Prof, Goulden, Nick, PhD, Wade, Rachel, MSc, Mitchell, Chris, FRCPCH, Hancock, Jeremy, PhD, Hough, Rachael, MD, Rowntree, Clare, PhD, Richards, Sue, DPhil
Published in The lancet oncology (01.03.2013)
Published in The lancet oncology (01.03.2013)
Get full text
Journal Article
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial
Vora, Ajay, Prof, Goulden, Nick, PhD, Mitchell, Chris, FRCPCH, Hancock, Jeremy, PhD, Hough, Rachael, MD, Rowntree, Clare, PhD, Moorman, Anthony V, Prof, Wade, Rachel, MSc
Published in The lancet oncology (01.07.2014)
Published in The lancet oncology (01.07.2014)
Get full text
Journal Article
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
Parker, Catriona, PhD, Waters, Rachel, MSc, Leighton, Carly, BNurs, Hancock, Jeremy, PhD, Sutton, Rosemary, PhD, Moorman, Anthony V, PhD, Ancliff, Philip, FRCPath, Morgan, Mary, MRCPath, Masurekar, Ashish, MD, Goulden, Nicholas, FRCPath, Green, Nina, Révész, Tamas, FRACP, Darbyshire, Philip, FRCPath, Love, Sharon, BSc, Saha, Vaskar, Prof
Published in The Lancet (British edition) (11.12.2010)
Published in The Lancet (British edition) (11.12.2010)
Get full text
Journal Article